Skip to content

May 9, 2026

ChatGPT Image May 7, 2026, 07_11_28 PM

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
M&A / Deals
UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies

M&A / Deals

UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies

PharmaTimes

Partnership builds on existing collaboration and adds two new UCBnominated projects

Read full story

pharminent May 7, 2026 (Last updated: May 8, 2026)

PharmaTimes

Partnership builds on existing collaboration and adds two new UCBnominated projects

Read full story

Post navigation

Previous: Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing

Next: Roche buys AI-powered diagnostics player PathAI

Related Stories

M&A / Deals

Angelini inks $4.1B Catalyst buy to enter US rare disease market

pharminent May 7, 2026

M&A / Deals

Roche buys AI-powered diagnostics player PathAI

pharminent May 7, 2026

M&A / Deals

Daiichi Sankyo and Waiv partner for ADC biomarkers

pharminent May 7, 2026

You May Have Missed

M&A / Deals

Angelini inks $4.1B Catalyst buy to enter US rare disease market

pharminent May 7, 2026

Regulatory

Bayer plans filings for cardiac amyloidosis imaging agent

pharminent May 7, 2026

M&A / Deals

Roche buys AI-powered diagnostics player PathAI

pharminent May 7, 2026

M&A / Deals

UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies

pharminent May 7, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.